Related Experiment Videos
[Hepatic fibrosis and its serum markers]
1Department of Medicine, St. Marianna University School of Medicine, Yokohama Seibu Hospital.
Rinsho Byori. the Japanese Journal of Clinical Pathology
|December 1, 1992
Summary
Serum markers like prolyl hydroxylase (PH) and type III procollagen peptide (PIIIP) reliably indicate ongoing liver fibrosis. Type IV collagen and laminin assess the extent of hepatic fibrosis, aiding clinical applications.
Area of Science:
- Biochemistry
- Hepatology
- Clinical Diagnostics
Context:
- Liver fibrosis is a significant health concern.
- Accurate assessment of fibrosis is crucial for patient management.
- Existing diagnostic methods have limitations.
Purpose:
- To evaluate the clinical utility of specific serum markers for liver fibrosis.
- To identify reliable indicators of fibrosis progression and extent.
Summary:
- Prolyl hydroxylase (PH), type III procollagen peptide (PIIIP), mesenchymal metalloproteinase (MMP), tissue inhibitor of metalloproteinase (TIMP), and laminin (LM) are validated serum markers for liver fibrosis.
- PH, PIIIP, MMP, TIMP, and LM indicate active hepatic fibrosis.
- Type IV collagen and LM correlate with the extent of liver fibrosis.
Impact:
- These markers offer reliable clinical tools for diagnosing and monitoring liver fibrosis.
- Improved assessment can lead to timely interventions and better patient outcomes.
- Facilitates non-invasive evaluation of liver fibrosis progression.